Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 16c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Privia Health Group Inc (PRVA) PT Raised to $32 at Citi
February 27, 2025 4:33 PM ESTCiti analyst Daniel Grosslight raised the price target on Privia Health Group Inc (NASDAQ: PRVA) to $32.00 (from $26.00) while maintaining a Buy rating.
The analyst comments "PRVA reported solid 4Q results beating guidance/expectations across the board. Practice collections grew ~5% y/y, as... More
